Aprepitant + Dexamethasone + Ondansetron + Dexamethasone
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Postoperative Nausea and Vomiting
Conditions
Postoperative Nausea and Vomiting
Trial Timeline
Sep 1, 2007 → Jun 1, 2009
NCT ID
NCT00734929About Aprepitant + Dexamethasone + Ondansetron + Dexamethasone
Aprepitant + Dexamethasone + Ondansetron + Dexamethasone is a approved stage product being developed by Merck for Postoperative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT00734929. Target conditions include Postoperative Nausea and Vomiting.
What happened to similar drugs?
20 of 20 similar drugs in Postoperative Nausea and Vomiting were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00734929 | Approved | Completed |
Competing Products
20 competing products in Postoperative Nausea and Vomiting